|
1.
|
Acarbose Tablets USP
|
Each film coated tablet contains:
Acarbose USP 100 mg
Excipients q.s.
Colour: Approved colour used.
|
|
2.
|
Acebrophylline(SR) Tablets
|
Each film coated sustained release tablet contains: Acebrophylline 200 mg
Excipients q.s.
Colour: Approved colour used.
|
|
3.
|
Acebrophylline(SR) Montelukast Tablets
|
Each film coated bilayered tablet contains:
Acebrophylline 200 mg
(As sustained release form) Montelukast Sodium IP
Eq. to Montelukast 10 mg
Excipients q.s.
Colour: Approved colour used
|
|
4.
|
Aceclofenac & Paracetamol Tablets
|
Each film coated tablet contains:
Aceclofenac IP 100 mg
Paracetamol IP 325 mg Excipients q.s.
Colour: Approved colour used
|
|
5.
|
Aceclofenac Sustained Release Tablets
|
Each film coated sustained release tablet contains:
Aceclofenac IP 200 mg
Excipients q.s.
Colour: Sunset Yellow FCF
|
|
6.
|
Aceclofenac Thiocolchicoside Tablets
|
Each film coated tablet contains:
Aceclofenac IP 100 mg
Thiocolchicoside IP 4 mg
Excipients q.s.
Colour: Approved colour used.
|
|
7.
|
Aciclovir Tablets IP
|
Each uncoated tablet contains:
Aciclovir IP 200 mg
Excipients q.s.
|
|
8.
|
Aciclovir Tablets IP
|
Each uncoated tablet contains:
Aciclovir IP 400 mg
Excipients q.s.
|
|
9.
|
Aciclovir Tablets IP
|
Each uncoated tablet contains:
Aciclovir IP 800 mg
Excipients q.s.
|
|
10.
|
Aciclovir Tablets IP
|
Each film coated tablet contains:
Aciclovir IP 400 mg
Excipients q.s.
Colour: Approved colour used.
|
|
11.
|
Alprazolam Tablets IP
|
Each uncoated tablet contains:
Alprazolam IP 0.25 mg
Excipients q.s.
|
|
12.
|
Alprazolam Tablets IP
|
Each uncoated tablet contains:
Alprazolam IP 0.5 mg
Excipients q.s.
|
|
13.
|
N-Acetylcysteine Tablets 600 mg
|
Each film coated tablet contains:
N-Acetylcysteine USP 600 mg Excipients q.s.
Colour: Approved colour used
|
|
14.
|
Albendazole Tablets IP
|
Each uncoated chewable tablet contains:
Albendazole IP 200 mg Excipients q.s.
Colour: Approved colour used
|
|
15.
|
Albendazole Tablets IP
|
Each uncoated chewable tablet contains:
Albendazole IP 400 mg Excipients q.s.
Colour: Approvedcolour used
|
|
16.
|
Albendazole Ivermect in Tablets
|
Each uncoated tablet contains:
Albendazole IP 400 mg
Ivermectin IP 12 mg
Excipients q.s.
Colour: Approved colour used
|
|
17.
|
Albendazole Ivermect in Tablets
|
Each uncoated tablet contains:
Albendazole IP 400 mg
Ivermectin IP 6 mg
Excipients q.s.
Colour: Approved colour used
|
|
18.
|
Amisulpiride Tablets IP
|
Each film coated tablet contains:
Amisulpiride IP 50 mg Excipients q.s.
Colour: Approved colour used
|
|
19.
|
Amisulpiride Tablets IP
|
Each film coated tablet contains:
Amisulpiride IP 100 mg Excipients q.s.
Colour: Approved colour used
|
|
20.
|
Amisulpride Tablets IP300 mg
|
Each uncoated tablet contains:
Amisulpride IP 300 mg
Excipients q.s.
|
|
21.
|
Amisulpride Tablets IP400 mg
|
Each uncoated tablet contains:
Amisulpride IP 400 mg
Excipients q.s.
|
|
22.
|
Amitriptyline Tablets IP
|
Each film coated tablet contains:
Amitriptyline Hydrochloride IP 10 mg Excipients q.s.
Colour: Lake Yellow Iron Oxide
|
|
23.
|
Amitriptyline Tablets IP
|
Each film coated tablet contains:
Amitriptyline Hydrochloride IP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
24.
|
Amlodipine Tablets IP
|
Each uncoated tablet contains:
Amlodipine Besylate IP
Equivalent to Amlodipine 5 mg Excipients q.s.
|
|
25.
|
Amlodipine Tablets IP
|
Each uncoated tablet contains:
Amlodipine Besylate IP
Equivalent to Amlodipine 10 mg Excipients q.s.
|
|
26.
|
Amlodipine & Atenolol Tablets IP
|
Each uncoated tablet contains:
Amlodipine Besylate IP
Equivalent to Amlodipine 5 mg
Atenolol IP 50 mg
Excipients q.s.
|
|
27.
|
Amlodipine Nebivolol Tablets IP
|
Each uncoated tablet contains:
Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Nebivolol Hydrochloride IP
Eq. to Nebivolol 5 mg
Excipients q.s.
|
|
28.
|
Anastrozole Tablets IP
|
Each film coated tablet contains:
Anastrozole IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
29.
|
Artemether Lumefantrine Tablets IP
|
Each film coated tablet contains:
Artemether IP 20 mg
Lumefantrine IP 120 mg Excipients q.s.
Colour: Approved colour used
|
|
30.
|
Artemether Lumefantrine Tablets IP
|
Each film coated tablet contains:
Artemether IP 80 mg
Lumefantrine IP 480 mg Excipients q.s.
Colour: Approved colour used
|
|
31.
|
Aspirin Tablets IP
|
Each film coated tablet contains:
Aspirin IP 75 mg Excipients q.s.
Colour: Approvedcolour used
|
|
32.
|
Aspirin Tablets IP
|
Each film coated tablet contains:
Aspirin IP 150 mg Excipients q.s.
Colour: Approved colour used
|
|
33.
|
Aspirin Tablets IP
|
Each film coated tablet contains:
Aspirin IP 300 mg Excipients q.s.
Colour: Approved colour used
|
|
34.
|
Aspirin Gastro-resistant Tablets IP
|
Each gastro-resistant tablet contains:
Aspirin IP 75 mg Excipients q.s.
Colour: Approved colour used
|
|
35.
|
Aspirin Gastro-resistant Tablets IP
|
Each gastro-resistant tablet contains:
Aspirin IP 150 mg Excipients q.s.
Colour: Approved colour used
|
|
36.
|
Ascorbic Acid Tablets IP
|
Each uncoated chewable tablet contains:
Ascorbic Acid IP 500 mg Excipients q.s.
Colour: Approved colour used
|
|
37.
|
Atorvastatin Tablets IP
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 10 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
38.
|
Atorvastatin Tablets IP
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 20 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
39.
|
Atorvastatin Tablets IP
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 20 mg Excipients q.s.
Colour: Sunset Yellow FCF & Titanium Dioxide IP
|
|
40.
|
Atorvastatin Tablets IP
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 40 mg Excipients q.s.
Colour: Approved colour used
|
|
41.
|
Atorvastatin Ezetimibe Tablets
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 10 mg
Ezetimibe IP 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
42.
|
Atorvastatin & Fenofibrate Tablets IP
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 10 mg
Fenofibrate IP 80 mg (Micronized)
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
43.
|
Atorvastatin & Fenofibrate Tablets IP
|
Each film coated tablet contains:
Atorvastatin Calcium IP
Equivalent to Atorvastatin 10 mg
Fenofibrate IP 145 mg (Micronized)
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
44.
|
Azithromycin Tablets IP
|
Each film coated tablet contains:
Azithromycin (Anhydrous) IP 250 mg (as Azithromycin dihydrate)
Excipients q.s.
Colour: Approved colour used
|
|
45.
|
Azithromycin Tablets IP
|
Each film coated tablet contains:
Azithromycin (Anhydrous) IP 500 mg (as Azithromycin dihydrate)
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
46.
|
Azithromycin Tablets USP (For Export Only)
|
Each film coated tablet contains: Azithromycin Dihydrate USP
Eq. to Azithromycin (Anhydrous) 250 mg Excipients q.s.
Colour: Approved colour used
|
|
47.
|
Azithromycin Tablets USP (For Export Only)
|
Each film coated tablet contains: Azithromycin Dihydrate USP
Eq. to Azithromycin (Anhydrous) 500 mg Excipients q.s.
Colour: Approved colour used
|
|
48.
|
Betahistine Tablets IP
|
Each uncoated tablet contains:
Betahistine Hydrochloride IP 4 mg
Excipients q.s.
|
|
49.
|
Betahistine Tablets IP
|
Each uncoated tablet contains:
Betahistine Hydrochloride IP 8 mg
Excipients q.s.
|
|
50.
|
Betahistine Tablets IP
|
Each uncoated tablet contains:
Betahistine Hydrochloride IP 16 mg Excipients q.s.
|
|
51.
|
Betahistine Hydrochloride Orally Disintegrating Tablets
|
Each uncoated orally disintegrating tablet contains:
Betahistine Hydrochloride IP 16 mg
Excipients q.s.
|
|
52.
|
Betahistine Hydrochloride Sustained-Release Tablets
|
Each film coated tablet contains:
Betahistine Hydrochloride IP 24 mg (As sustained-release form)
Excipients q.s.
Colour: Approved colour used.
|
|
53.
|
Betamethasone Sodium Phosphate Tablets IP
|
Each uncoated tablet contains:
Betamethasone Sodium Phosphate IP
Equivalent to Betamethasone 0.5 mg
Excipients q.s.
|
|
54.
|
Bilastine Tablets
|
Each film coated tablet contains:
Bilastine 20 mg
Excipients q.s.
Colour: Approved colour used
|
|
55.
|
Bilastine Montelukast Sodium Tablets
|
Each film coated tablet contains:
Bilastine 20 mg
Montelukast Sodium IP
Equivalent to Montelukast 10 mg Excipients q.s.
Colour: Approved colour used
|
|
56.
|
Bisoprolol Fumarate Tablets USP
|
Each film coated tablet contains:
Bisoprolol Fumarate USP 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
57.
|
Buspirone Hydrochloride Tablets IP
|
Each uncoated tablet contains:
Buspirone Hydrochloride IP
Eq. to Buspirone 10 mg
Excipients q.s.
|
|
58.
|
Carvedilol Tablets IP 3.125 mg
|
Each film coated tablet contains:
Carvedilol IP 3.125 mg
Excipients q.s.
Colour: Approved colour used.
|
|
59.
|
Carvedilol Tablets IP 6.25 mg
|
Each film coated tablet contains:
Carvedilol IP 6.25 mg
Excipients q.s.
Colour: Approved colour used.
|
|
60.
|
Carvedilol Tablets IP 12.5 mg
|
Each film coated tablet contains:
Carvedilol IP 12.5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
61.
|
Carvedilol Tablets IP 25 mg
|
Each film coated tablet contains:
Carvedilol IP 25 mg
Excipients q.s.
Colour: Approved colour used.
|
|
62.
|
Cetirizine Dihydrochloride Tablets IP
|
Each film coated tablet contains:
Cetirizine Dihydrochloride IP 5 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
63.
|
Chlorpheniramine Tablets IP
|
Each uncoated tablet contains:
Chlorpheniramine Maleate IP 4 mg Excipients q.s.
|
|
64.
|
Chlorpheniramine Tablets IP
|
Each uncoated tablet contains:
Chlorpheniramine Maleate IP 8 mg
Excipients q.s.
|
|
65.
|
Chlorthalidone Tablets IP
|
Each film coated tablet contains:
Chlorthalidone IP 12.5 mg Excipients q.s.
Colour: Approved colour used.
|
|
66.
|
Cinnarizine Tablets IP 25 mg
|
Each uncoated tablet contains:
Cinnarizine IP 25 mg
Excipients q.s.
|
|
67.
|
Ciprofloxacin Hydrochloride Tablets IP
|
Each film coated tablet contains:
Ciprofloxacin Hydrochloride IP
Equivalent to Ciprofloxacin 250 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
68.
|
Ciprofloxacin Hydrochloride Tablets IP
|
Each film coated tablet contains:
Ciprofloxacin Hydrochloride IP
Equivalent to Ciprofloxacin 500 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
69.
|
Ciprofloxacin Tablets USP 500 mg (For Export only)
|
Each film coated tablet contains: Ciprofloxacin Hydrochloride USP
Eq. to Ciprofloxacin 500 mg .
Excipients q.s.
Colour: Approved colour used.
|
|
70.
|
CiticolineSodium Tablets IP
|
Each film coated tablet contains:
Citicoline Sodium IP
Equivalent to Citicoline 250 mg Excipients q.s.
Colour: Approved colour used
|
|
71.
|
Citicoline Sodium Tablets IP
|
Each film coated tablet contains:
Citicoline Sodium IP
Equivalent to Citicoline 500 mg Excipients q.s.
Colour: Approved colour used
|
|
72.
|
Citicoline Sodium & Piracetam Tablets
|
Each film coated tablet contains:
Citicoline Sodium IP
Equivalent to Citicoline 500 mg
Piracetam IP 400 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
73.
|
Citicoline Piracetam Tablets
|
Each film coated tablet contains:
Citicoline Sodium IP
Equivalent to Citicoline 500 mg
Piracetam IP 800 mg
Excipients q.s.
Colour: Approved colour used
|
|
74.
|
Cilnidipine Tablets IP5 mg
|
Each film coated tablet contains:
Cilnidipine IP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
75.
|
Cilnidipine Tablets IP 10 mg
|
Each film coated tablet contains:
Cilnidipine IP 10 mg
Excipients q.s.
Colour: Approved colour used
|
|
76.
|
Cilnidipine Tablets IP 20 mg
|
Each film coated tablet contains:
Cilnidipine IP 20 mg
Excipients q.s.
Colour: Approved colour used
|
|
77.
|
Cilnidipine & Telmisartan Tablets
|
Each film coated tablet contains:
Cilnidipine IP 10 mg
Telmisartan IP 40 mg
Excipients q.s.
Colour: Approved colour used.
|
|
78.
|
Cilostazol Tablets IP 50 mg
|
Each uncoated tablet contains:
Cilostazol IP 50 mg
Excipients q.s.
|
|
79.
|
Clonidine Tablets IP 100 mcg
|
Each uncoated tablet contains:
Clonidine Hydrochloride IP 100 mcg
Excipients q.s.
|
|
80.
|
Clonidine Tablets IP 300 mcg
|
Each uncoated tablet contains:
Clonidine Hydrochloride IP 300 mcg
Excipients q.s.
|
|
81.
|
Clopidogrel Tablets IP
|
Each film coated tablet contains:
Clopidogrel Bisulphate IP
Equivalent to Clopidogrel 75 mg Excipients q.s.
Colour: Approved colour used
|
|
82.
|
Clotrimazole Pessaries IP
|
Each uncoated tablet contains:
Clotrimazole IP 100 mg Excipients q.s.
|
|
83.
|
Clotrimazole Pessaries IP
|
Each uncoated tablet contains:
Clotrimazole IP 200 mg Excipients q.s.
|
|
84.
|
Clotrimazole Pessaries IP
|
Each uncoated tablet contains:
Clotrimazole IP 500 mg Excipients q.s.
|
|
85.
|
Dapagliflozin Tablets 10 mg
|
Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate IP
Eq. to Dapagliflozin 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
86.
|
Dapagliflozin Metformin Hydrochloride (ER) Tablets
|
Each film coated tablet contains:
Dapagliflozin Propanediol Monohydrate IP
Eq. to Dapagliflozin 10 mg
Metformin Hydrochloride IP 500 mg (As extended release form)
Excipients q.s.
Colour: Approved colour used.
|
|
87.
|
Deflazacort Tablets
|
Each uncoated tablet contains:
Deflazacort 6 mg
Excipients q.s.
|
|
88.
|
Deflazacort Tablets
|
Each uncoated tablet contains:
Deflazacort 12 mg
Excipients q.s.
|
|
89.
|
Deflazacort Tablets
|
Each uncoated tablet contains:
Deflazacort 30 mg
Excipients q.s.
|
|
90.
|
Dexchlorpheniramine Maleate Tablets IP
|
Each uncoated tablet contains:
Dexchlorpheniramine Maleate IP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
91.
|
Dextromethorphan, Phenylephrine Hydrochloride Chlorpheniramine Maleate Tablets
|
Each uncoated tablet contains:
Dextromethorphan Hydrobromide IP 10 mg
Phenylephrine Hydrochloride IP 5 mg
Chlorpheniramine Maleate IP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
92.
|
Diacerein, Glucosamine & Methyl Sulfonyl Methane Tablets
|
Each film coated tablet contains:
Diacerein IP 50 mg
Glucosamine Sulphate IP 750 mg
Methyl Sulfonyl Methane USP 250 mg Excipients q.s.
Colour: Yellow Oxide of Iron & Titanium Dioxide IP
|
|
93.
|
Diclofenac Sodium & Paracetamol Tablets IP
|
Each uncoated tablet contains:
Diclofenac Sodium IP 50 mg
Paracetamol IP 325 mg
Excipients q.s.
|
|
94.
|
Diclofenac Gastro-resistant Tablets
|
Each enteric coated tablet contains:
Diclofenac Sodium IP 50 mg Excipients q.s.
Colour: Iron Oxide Red USP-NF & Titanium Dioxide IP
|
|
95.
|
Diclofenac Potassium Tablets USP (For Export only)
|
Each film coated tablet contains:
Diclofenac Potassium BP 75 mg .
Excipients q.s.
Colour: Approved colour used.
|
|
96.
|
Diclofenac Potassium, Paracetamol Chlorzoxazone Tablets
|
Each uncoated tablet contains:
Diclofenac Potassium IP 50 mg
Paracetamol IP 325 mg
Chlorzoxazone USP 250 mg Excipients q.s.
Colour: Approved colour used
|
|
97.
|
Disulfiram Tablets IP
|
Each uncoated tablet contains:
Disulfiram IP 500 mg
Excipients q.s.
|
|
98.
|
Dicyclomine Hydrochloride Tablets IP
|
Each uncoated tablet contains:
Dicyclomine Hydrochloride IP 10 mg Excipients q.s.
|
|
99.
|
Dicyclomine Hydrochloride Tablets IP
|
Each uncoated tablet contains:
Dicyclomine Hydrochloride IP 20 mg Excipients q.s.
|
|
100.
|
Donepezil Tablets IP
|
Each film coated tablet contains:
Donepezil Hydrochloride IP 5 mg Excipients q.s.
Colour: Approved colour used
|
|
101.
|
Donepezil Tablets IP
|
Each film coated tablet contains:
Donepezil Hydrochloride IP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
102.
|
Donepezil Memantine Tablets
|
Each film coated tablet contains:
Donepezil Hydrochloride IP 5 mg
Memantine Hydrochloride IP 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
103.
|
Doxofylline Tablets IP
|
Each uncoated tablet contains:
Doxofylline IP 400 mg
Excipients q.s.
|
|
104.
|
Drotaverine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Drotaverine Hydrochloride IP 40 mg Excipients q.s.
Colour: Approved colour used
|
|
105.
|
Drotaverine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Drotaverine Hydrochloride IP 80 mg Excipients q.s.
Colour: Approved colour used
|
|
106.
|
Drotaverine Hydrochloride & Mefenamic Acid Tablets
|
Each film coated tablet contains:
Drotaverine Hydrochloride IP 40 mg
Mefenamic Acid IP 250 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
107.
|
Drotaverine Hydrochloride & Mefenamic Acid Tablets
|
Each film coated tablet contains:
Drotaverine Hydrochloride IP 80 mg
Mefenamic Acid IP 250 mg Excipients q.s.
Colour: Approved colour used
|
|
108.
|
Doxofylline(SR) Montelukast Tablets
|
Each uncoated bilayered tablet contains:
Doxofylline IP 400 mg (As sustained release form)
Montelukast Sodium IP
Eq. to Montelukast 10 mg
Excipients q.s.
Colour: Approved colour used
|
|
109.
|
Doxylamine Tablets USP
|
Each film coated tablet contains:
Doxylamine Succinate USP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
110.
|
Doxylamine Tablets USP 25 mg
|
Each film coated tablet contains:
Doxylamine Succinate USP 25 mg Excipients q.s.
Colour: Approved colour used
|
|
111.
|
Ebastine Tablets IP
|
Each uncoated tablet contains:
Ebastine IP 20 mg
Excipients q.s.
|
|
112.
|
Ebastine Phenylephrine Hydrochloride Tablets
|
Each film coated tablet contains:
Ebastine IP 10 mg
Phenylephrine Hydrochloride IP 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
113.
|
Empagliflozin Tablets 10 mg
|
Each film coated tablet contains:
Empagliflozin 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
114.
|
Empagliflozin Tablets 25 mg
|
Each film coated tablet contains:
Empagliflozin 25 mg
Excipients q.s.
Colour: Approved colour used.
|
|
115.
|
Enalapril Maleate Tablets IP
|
Each uncoated tablet contains:
Enalapril Maleate IP 2.5 mg Excipients q.s.
Colour: Approved colour used
|
|
116.
|
Enalapril Maleate Tablets IP
|
Each uncoated tablet contains:
Enalapril Maleate IP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
117.
|
Etoricoxib Tablets
|
Each film coated tablet contains:
Etoricoxib IP 60 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
118.
|
Etoricoxib Tablets
|
Each film coated tablet contains:
Etoricoxib IP 90 mg
Excipients q.s.
Colour: Iron Oxide Red USP-NF & Titanium Dioxide IP
|
|
119.
|
Etoricoxib Tablets IP
|
Each film coated tablet contains:
Etoricoxib IP 90 mg
Excipients q.s.
Colour: Approved colour used.
|
|
120.
|
Etoricoxib Tablets IP
|
Each film coated tablet contains:
Etoricoxib IP 120 mg
Excipients q.s.
Colour: Approved colour used.
|
|
121.
|
Etoricoxib Paracetamol Tablets
|
Each film coated tablet contains:
Etoricoxib IP 60 mg
Paracetamol IP 325 mg Excipients q.s.
Colour: Approved colour used.
|
|
122.
|
Etoricoxib & Thiocolchicoside Tablets
|
Each film coated tablet contains:
Etoricoxib IP 60 mg
Thiocolchicoside IP 4 mg
Excipients q.s.
Colour: Sunset Yellow FCF & Titanium Dioxide IP
|
|
123.
|
Etoricoxib & Thiocolchicoside Tablets
|
Each film coated tablet contains:
Etoricoxib IP 60 mg
Thiocolchicoside IP 4 mg
Excipients q.s.
Colour: Approved colour used.
|
|
124.
|
Febuxostat Tablets
|
Each film coated tablet contains:
Febuxostat 40 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
125.
|
Febuxostat Tablets
|
Each film coated tablet contains:
Febuxostat 80 mg
Excipients q.s.
Colour: Approved colour used
|
|
126.
|
Fexofenadine Tablets IP
|
Each film coated tablet contains:
Fexofenadine Hydrochloride IP 120 mg
Excipients q.s.
Colour: Ironoxide Yellow USP-NF, Ironoxide Red USP-NF & Titanium Dioxide IP
|
|
127.
|
Fexofenadine Hydrochloride & Montelukast Sodium Tablets IP
|
Each film coated tablet contains:
Fexofenadine Hydrochloride IP 120 mg
Montelukast Sodium IP 10 mg
Excipients q.s.
Colour: Ironoxide Yellow USP-NF & Titanium Dioxide IP
|
|
128.
|
Finasteride Tablets IP
|
Each film coated tablet contains:
Finasteride IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
129.
|
Finasteride Tablets IP
|
Each film coated tablet contains:
Finasteride IP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
130.
|
Fluconazole Tablets IP
|
Each uncoated tablet contains:
Fluconazole IP 150 mg
Excipients q.s.
|
|
131.
|
Flupentixol Melitracen Hydrochloride Tablets
|
Each film coated tablet contains:
Flupentixol Hydrochloride BP
Eq. to Flupentixol 0.5 mg
Melitracen Hydrochloride
Eq. to Melitracen 10 mg
Excipients q.s.
Colour: Approved colour used
|
|
132.
|
Flupirtine Maleate Tablets
|
Each film coated sustained release tablet contains:
Flupirtine Maleate 400 mg
Excipients q.s.
Colour: Approved colour used.
|
|
133.
|
Flupirtine Maleate Paracetamol Tablets
|
Each film coated tablet contains:
Flupirtine Maleate 100 mg
Paracetamol IP 325 mg Excipients q.s.
Colour: Approved colour used.
|
|
134.
|
Fluoxetine Hydrochloride Tablets IP
|
Each film coatedtablet contains: Fluoxetine Hydrochloride IP
Eq. to Fluoxetine 60 mg
Excipients q.s.
Colour: Approved colour used.
|
|
135.
|
Gabapentin Tablets
|
Each film coated tablet contains:
Gabapentin IP 100 mg
Excipients q.s.
Colour: Ponceau 4R & Titanium Dioxide IP
|
|
136.
|
Gabapentin Tablets IP
|
Each film coated tablet contains:
Gabapentin IP 300 mg
Excipients q.s.
Colour: Approved colour used
|
|
137.
|
Gabapentin Tablets IP
|
Each film coated tablet contains:
Gabapentin IP 400 mg
Excipients q.s.
Colour: Approved colour used
|
|
138.
|
Gabapentin Nortriptyline Hydrochloride Tablets
|
Each film coated tablet contains:
Gabapentin IP 100 mg
Nortriptyline Hydrochloride IP
Eq. to Nortriptyline 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
139.
|
Gabapentin Amitriptyline Hydrochloride Tablets
|
Each film coated tablet contains:
Gabapentin IP 100 mg
Amitriptyline Hydrochloride IP 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
140.
|
Gabapentin Amitriptyline Hydrochloride Tablets
|
Each film coated tablet contains:
Gabapentin IP 400 mg
Amitriptyline Hydrochloride IP 10 mg Excipients q.s.
Colour: Approved colour used.
|
|
141.
|
Glimepiride Tablets IP 1 mg
|
Each uncoated tablet contains:
Glimepiride IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
142.
|
Glimepiride Tablets IP 2 mg
|
Each uncoated tablet contains:
Glimepiride IP 2 mg
Excipients q.s.
Colour: Approved colour used
|
|
143.
|
Glimepiride & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Glimepiride IP 1 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
144.
|
Glimepiride & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Glimepiride IP 2 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Excipients q.s.
Colour: Ponceau4R
|
|
145.
|
Glimepiride & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Glimepiride IP 1 mg
Metformin Hydrochloride IP 850 mg (Sustained release)
Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
146.
|
Glimepiride, Voglibose & Metformin HCl Tablets
|
Each uncoated tablet contains:
Glimepiride IP 2 mg
Voglibose IP 0.2 mg
Metformin Hydrochloride IP 500 mg Excipients q.s.
|
|
147.
|
Glimepiride, Voglibose & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Glimepiride IP 1 mg
Voglibose IP 0.2 mg
Metformin Hydrochloride IP 500 mg (As sustained-release form)
Excipients q.s.
Colour: Approved colour used
|
|
148.
|
Glimepiride, Voglibose & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Glimepiride IP 2 mg
Voglibose IP 0.2 mg
Metformin Hydrochloride IP 500 mg (As sustained-release form)
Excipients q.s.
Colour: Approved colour used
|
|
149.
|
Gliclazide Tablets IP 80 mg
|
Each uncoated tablet contains:
Gliclazide IP 80 mg
Excipients q.s.
|
|
150.
|
Gliclazide, Metformin Hydrochloride Pioglitazone Tablets
|
Each uncoated bilayered tablet contains:
Gliclazide IP 80 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone 15 mg Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
151.
|
Gliclazide, Metformin Hydrochloride Pioglitazone Tablets
|
Each uncoated bilayered tablet contains:
Gliclazide IP 40 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone 15 mg Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
152.
|
Glipizide & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Glipizide IP 5 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
153.
|
Hydroxyzine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Hydroxyzine Hydrochloride IP 25 mg Excipients q.s.
Colour: Approved colour used.
|
|
154.
|
Ibuprofen & Paracetamol Tablets IP
|
Each uncoated tablet contains:
Ibuprofen IP 400 mg
Paracetamol IP 325 mg Excipients q.s.
|
|
155.
|
Indapamide Sustained release Tablets
|
Each film-coated sustained release tablet contains: Indapamide IP 1.5 mg
Excipients q.s.
Colour: Titanium Dioxide IP Sunset Yellow FCF
|
|
156.
|
Isosorbide Mononitrate Tablets IP
|
Each uncoated tablet contains:
Diluted Isosorbide Mononitrate IP
Eq. to Isosorbide Mononitrate 10 mg Excipients q.s.
|
|
157.
|
Isosorbide Mononitrate Tablets IP
|
Each uncoated tablet contains:
Diluted Isosorbide Mononitrate IP
Eq. to Isosorbide Mononitrate 30 mg Excipients q.s.
|
|
158.
|
Isosorbide Mononitrate Tablets IP
|
Each uncoated tablet contains:
Diluted Isosorbide Mononitrate IP
Eq. to Isosorbide Mononitrate 60 mg Excipients q.s.
|
|
159.
|
Isosorbide Mononitrate Prolonged Release Tablets BP
|
Each film coated prolonged release tablet contains: Diluted Isosorbide Mononitrate IP
Eq. to Isosorbide Mononitrate 30 mg Excipients q.s.
Colour: Approved colour used.
|
|
160.
|
Isoxsuprine Hydrochloride Tablets IP
|
Each film coated sustained release tablet contains:
Isoxsuprine Hydrochloride IP 10 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
161.
|
Isoxsuprine Tablets IP
|
Each film coated sustained release tablet contains: Isoxsuprine Hydrochloride IP 20 mg Excipients q.s.
Colours: Sunset Yellow FCF & Titanium Dioxide IP
|
|
162.
|
Isoxsuprine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Isoxsuprine Hydrochloride IP 20 mg Excipients q.s.
Colour: Approved colour used.
|
|
163.
|
Itopride Hydrochloride Tablets IP 50 mg
|
Each film coated tablet contains:
Itopride Hydrochloride IP 50 mg Excipients q.s.
Colour: Approved colour used.
|
|
164.
|
Ivermectin Tablets IP
|
Each uncoated tablet contains:
Ivermectin IP 3 mg
Excipients q.s.
|
|
165.
|
Ivermectin Tablets IP
|
Each uncoated tablet contains:
Ivermectin IP 6 mg
Excipients q.s.
|
|
166.
|
Ivermectin Tablets IP
|
Each uncoated tablet contains:
Ivermectin IP 12 mg
Excipients q.s.
|
|
167.
|
Ketoconazole Tablets IP
|
Each uncoated tablet contains:
Ketoconazole IP 200 mg Excipients q.s.
|
|
168.
|
Ketorolac Tromethamine Dispersible Tablets 10 mg
|
Each uncoated dispersible tablet contains:
Ketorolac Tromethamine IP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
169.
|
Labetalol Tablets IP
|
Each film coated tablet contains:
Labetalol Hydrochloride IP 100 mg Excipients q.s.
Colour: Approved colour used
|
|
170.
|
Labetalol Tablets IP
|
Each film coated tablet contains:
Labetalol Hydrochloride IP 200 mg Excipients q.s.
Colour: Approved colour used
|
|
171.
|
Labetalol Tablets IP
|
Each film coated tablet contains:
Labetalol Hydrochloride IP 400 mg Excipients q.s.
Colour: Approved colour used
|
|
172.
|
Lamotrigine Dispersible Tablets IP
|
Each uncoated dispersible tablet contains:
Lamotrigine IP 25 mg
Excipients q.s.
|
|
173.
|
Letrozole Tablets IP
|
Each film coated tablet contains:
Letrozole IP 2.5 mg
Excipients q.s.
Colour: Approved colour used
|
|
174.
|
Letrozole Tablets IP
|
Each film coated tablet contains:
Letrozole IP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
175.
|
Levocetirizine Tablets IP
|
Each film coated tablet contains:
Levocetirizine Hydrochloride IP 5 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
176.
|
Levocetirizine Hydrochloride, Phenylephrine Hydrochloride Paracetamol Tablets
|
Each uncoated tablet contains:
Levocetirizine Hydrochloride IP 5 mg
Phenylephrine Hydrochloride IP 5 mg
Paracetamol IP 325 mg
Excipients q.s.
|
|
177.
|
Levofloxacin Tablets IP
|
Each film coated tablet contains:
Levofloxacin Hemihydrate IP
Eq. to Levofloxacin 500 mg
Excipients q.s.
Colours: IronOxide Red USP-NF & Titanium Dioxide IP
|
|
178.
|
Levofloxacin Tablets IP
|
Each film coated tablet contains:
Levofloxacin Hemihydrate IP
Eq. to Levofloxacin 250 mg
Excipients q.s.
Colours: Iron Oxide Red USP-NF & Titanium Dioxide IP
|
|
179.
|
Levofloxacin Tablets IP
|
Each film coated tablet contains: Levofloxacin Hemihydrate IP
Eq. to Levofloxacin 500 mg
Excipients q.s.
Colour: Approved colour used
|
|
180.
|
Levofloxacin Tablets USP (For Export Only)
|
Each film coated tablet contains: Levofloxacin Hemihydrate USP
Eq. to Levofloxacin 250 mg
Excipients q.s.
Colour: Approved colour used
|
|
181.
|
Levofloxacin Tablets USP (For Export Only)
|
Each film coated tablet contains: Levofloxacin Hemihydrate USP
Eq. to Levofloxacin 500 mg
Excipients q.s.
Colour: Approved colour used
|
|
182.
|
Levosulpiride Tablets
|
Each uncoated tablet contains:
Levosulpiride 25 mg
Excipients q.s.
|
|
183.
|
Levetiracetam Tablets IP
|
Each film coated tablet contains:
Levetiracetam IP 250 mg Excipients q.s.
Colour: Approved colour used
|
|
184.
|
Levetiracetam Tablets IP
|
Each film coated tablet contains:
Levetiracetam IP 250 mg Excipients q.s.
Colours: Ironoxide Red USP-NF & Titanium Dioxide IP
|
|
185.
|
Levetiracetam Tablets IP
|
Each film coated tablet contains:
Levetiracetam IP 500 mg Excipients q.s.
Colour: Approved colour used
|
|
186.
|
Levetiracetam Tablets IP
|
Each film coated tablet contains:
Levetiracetam IP 500 mg Excipients q.s.
Colours: Ironoxide Red USP-NF, Erythrosine & Titanium Dioxide IP
|
|
187.
|
Levetiracetam Tablets IP
|
Each film coated tablet contains:
Levetiracetam IP 1000 mg Excipients q.s.
Colour: Approved colour used
|
|
188.
|
Levetiracetam Prolonged-release Tablets IP
|
Each film coated Prolonged-release tablet contains: Levetiracetam IP 500 mg Excipients q.s.
Colours: Sunset Yellow FCF & Titanium Dioxide IP
|
|
189.
|
Linagliptin Tablets
|
Each film coated tablet contains:
Linagliptin 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
190.
|
Linezolid Tablets IP
|
Each film coated tablet contains:
Linezolid IP 600 mg
Excipients q.s.
Colour: Approved colour used
|
|
191.
|
Loratadine Tablets IP
|
Each uncoated tablet contains:
Loratadine IP 10 mg
Excipients q.s.
|
|
192.
|
Losartan Potassium Tablets IP
|
Each film coated tablet contains:
Losartan Potassium IP 50 mg Excipients q.s.
Colour: Approved colour used
|
|
193.
|
Losartan Potassium Tablets IP
|
Each film coated tablet contains:
Losartan Potassium IP 25 mg Excipients q.s.
Colour: Approved colour used.
|
|
194.
|
Losartan Potassium & Hydrochlorothiazide Tablets IP
|
Each film coated tablet contains:
Losartan Potassium IP 50 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
Colour: Lakeof Erythrosine & Titanium Dioxide IP
|
|
195.
|
Losartan Potassium & Hydrochlorothiazide Tablets IP
|
Each film coated tablet contains:
Losartan Potassium IP 50 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
Colour: Approved colour used.
|
|
196.
|
Losartan Potassium & Amlodipine Tablets
|
Each uncoated tablet contains:
Losartan Potassium IP 25 mg
Amlodipine Besylate IP 5 mg
Excipients q.s.
|
|
197.
|
Mefenamic Acid Tablets IP
|
Each uncoated tablet contains:
Mefenamic Acid IP 250 mg Excipients q.s.
Colour: Approved colour used
|
|
198.
|
MefenamicAcid Tablets BP
|
Each uncoated tablet contains:
Mefenamic Acid IP 250 mg Excipients q.s.
Colour: Approved colour used
|
|
199.
|
Meloxicam Tablets BP 7.5 mg
|
Each uncoated tablet contains:
Meloxicam BP 7.5 mg
Excipients q.s.
|
|
200.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (as prolonged-release)
Glimepiride IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
201.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (As prolonged-release)
Glimepiride IP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
202.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 500 mg (as prolonged-release)
Glimepiride IP 3 mg
Excipients q.s.
Colour: Approved colour used
|
|
203.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains
Metformin Hydrochloride IP 850 mg (as prolonged-release)
Glimepiride IP 3 mg
Excipients q.s.
Colour: Approved colour used
|
|
204.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (as prolonged-release)
Glimepiride IP 3 mg
Excipients q.s.
Colour: Approved colour used
|
|
205.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 500 mg (as prolonged-release)
Glimepiride IP 4 mg
Excipients q.s.
Colour: Approved colour used
|
|
206.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (as prolonged-release)
Glimepiride IP 4 mg
Excipients q.s.
Colour: Approved colour used
|
|
207.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (as prolonged-release)
Glimepiride IP 2 mg
Excipients q.s.
Colour: SunsetYellow FCF
|
|
208.
|
Metformin Hydrochloride (SR), Pioglitazone Glimepiride Tablets
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 500 mg (as sustained-release form)
Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone 15 mg
Glimepiride IP 2 mg
Excipients q.s.
Colour: Approved colour used
|
|
209.
|
Metformin Hydrochloride (SR), Pioglitazone Glimepiride Tablets
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 500 mg (as sustained-release form)
Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone 15 mg
Glimepiride IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
210.
|
Metformin Hydrochloride (SR), Pioglitazone Glimepiride Tablets
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (As sustained-release form)
Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone 15 mg
Glimepiride IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
211.
|
Metformin Hydrochloride (SR), Pioglitazone Glimepiride Tablets
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 1000 mg (As sustained-release form)
Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone 15 mg
Glimepiride IP 2 mg
Excipients q.s.
Colour: Approved colour used
|
|
212.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 500 mg (as prolonged-release)
Glimepiride IP 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
213.
|
Metformin Hydrochloride Prolonged-release Glimepiride Tablets IP
|
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP 500 mg (as prolonged-release)
Glimepiride IP 2 mg
Excipients q.s.
Colour: Approved colour used
|
|
214.
|
Metformin Hydrochloride Tablets IP
|
Each uncoated tablet contains:
Metformin Hydrochloride IP 500 mg
Excipients q.s.
|
|
215.
|
Metformin Hydrochloride Tablets IP
|
Each uncoated sustained-release tablet contains:
Metformin Hydrochloride IP 500 mg Excipients q.s.
|
|
216.
|
Metformin Hydrochloride Tablets IP
|
Each uncoated tablet contains:
Metformin Hydrochloride IP 1000 mg Excipients q.s.
|
|
217.
|
Metformin Hydrochloride Tablets IP
|
Each uncoated tablet contains:
Metformin Hydrochloride IP 1000 mg (Sustained-release)
Excipients q.s.
|
|
218.
|
Metformin Hydrochloride & Gliclazide Tablets
|
Each uncoated tablet contains:
Metformin Hydrochloride IP 500 mg
Gliclazide IP 80 mg
Excipients q.s.
Colour: Erythrosine Supra
|
|
219.
|
Metformin Hydrochloride Gliclazide Tablets
|
Each uncoated tablet contains:
Metformin Hydrochloride IP 500 mg
Gliclazide IP 80 mg
Excipients q.s.
Colour: Approved colour used
|
|
220.
|
Mefenamic Acid Paracetamol Tablets
|
Each uncoated tablet contains:
Mefenamic Acid IP 500 mg
Paracetamol IP 325 mg Excipients q.s.
|
|
221.
|
Mefenamic Acid Dicyclomine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Mefenamic Acid IP 250 mg
Dicyclomine Hydrochloride IP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
222.
|
Mefenamic Acid Dicyclomine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Mefenamic Acid IP 250 mg
Dicyclomine Hydrochloride IP 20 mg Excipients q.s.
Colour: Approved colour used
|
|
223.
|
Mefenamic Acid Dicyclomine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Mefenamic Acid IP 500 mg
Dicyclomine Hydrochloride IP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
224.
|
Mefenamic Acid Dicyclomine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Mefenamic Acid IP 500 mg
Dicyclomine Hydrochloride IP 20 mg Excipients q.s.
Colour: Approved colour used
|
|
225.
|
Metoprolol Succinate Tablets IP
|
Each film coated tablet contains:
Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
226.
|
Metoprolol Succinate Tablets IP
|
Each film coated tablet contains:
Metoprolol Succinate IP 47.5 mg
Eq. to Metoprolol Tartrate 50 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
227.
|
Metoprolol Succinate Extended-release Tablets IP
|
Each film coated extended-release tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg Excipients q.s.
Colour: Approvedcolour used.
|
|
228.
|
Metoprolol Succinate Extended-release Tablets IP
|
Each film coated extended-release tablet contains: Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg Excipients q.s.
Colour: Approved colour used.
|
|
229.
|
Metoprolol Succinate Prolonged-release Amlodipine Tablets IP
|
Each film coated bilayered tablet contains:
Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As prolonged- release form)
Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
230.
|
Metoprolol Succinate(ER) Ramipril Tablets
|
Each film coated bilayered tablet contains:
Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended release form)
Ramipril IP 2.5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
231.
|
Metoprolol Succinate(ER) Ramipril Tablets
|
Each film coated bilayered tablet contains:
Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As extended release form)
Ramipril IP 2.5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
232.
|
Metoprolol Succinate(ER) Ramipril Tablets
|
Each film coated bilayered tablet contains:
Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As extended release form)
Ramipril IP 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
233.
|
Methylprednisolone Tablets IP
|
Each uncoated tablet contains:
Methylprednisolone IP 4 mg
Excipients q.s.
|
|
234.
|
Methylprednisolone Tablets IP
|
Each uncoated tablet contains:
Methylprednisolone IP 8 mg
Excipients q.s.
|
|
235.
|
Methylprednisolone Tablets IP
|
Each uncoated tablet contains:
Methylprednisolone IP 16 mg
Excipients q.s.
|
|
236.
|
Mirabegron Extended Release Tablets 25 mg
|
Each film coated extended release tablet contains: Mirabegron 25 mg
Excipients q.s.
Colour: Approved colour used.
|
|
237.
|
Mirabegron Extended Release Tablets 50 mg
|
Each film coated extended release tablet contains: Mirabegron 50 mg
Excipients q.s.
Colour: Approved colour used.
|
|
238.
|
Montelukast & Levocetirizine Tablets IP
|
Eachmouth Dissolving tablet contains: Montelukast Sodium IP
Eq. to Montelukast 5 mg
Levocetirizine hydrochloride IP 2.5 mg Excipients q.s.
Colour: Quinoline Yellow
|
|
239.
|
Montelukast & Levocetirizine Tablets IP
|
Eachmouth Dissolving tablet contains: Montelukast Sodium IP
Eq. to Montelukast 10 mg
Levocetirizine hydrochloride IP 5 mg
Excipients q.s.
Colour: Quinoline Yellow
|
|
240.
|
Montelukast & Levocetirizine Tablets IP
|
Each film coated tablet contains:
Montelukast Sodium IP
Eq. to Montelukast 10 mg
Levocetirizine hydrochloride IP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
241.
|
Montelukast Sodium & Levocetirizine Dihydrochloride Tablets
(For Export only)
|
Each film coated tablet contains:
Montelukast Sodium BP
Eq. to Montelukast 10 mg
Levocetirizine Dihydrochloride USP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
242.
|
Montelukast Sodium & Levocetirizine Dihydrochloride Dispersible Tablets
|
Each uncoated dispersible tablet contains: Montelukast Sodium IP
Eq. to Montelukast 4 mg
Levocetirizine Hydrochloride IP 2.5 mg Excipients q.s.
|
|
243.
|
Montelukast Sodium Fexofenadine Hydrochloride Tablets
|
Each film coated tablet contains:
Montelukast Sodium IP
Eq. to Montelukast 10 mg
Fexofenadine Hydrochloride IP 120 mg Excipients q.s.
Colour: Approved colour used
|
|
244.
|
Mycophenolic Acid Delayed-Release Tablets USP
|
Each enteric coated tablet contains: Mycophenolate Sodium USP
Equivalent to Mycophenolic Acid 360 mg Excipients q.s.
Colour: Approved colour used
|
|
245.
|
Mycophenolate Mofetil Tablets IP 500 mg
|
Each film coated tablet contains:
Mycophenolate Mofetil IP 500 mg Excipients q.s.
Colour: Approved colour used
|
|
246.
|
Naproxen Domperidone Tablets
|
Each film coated tablet contains:
Naproxen IP 250 mg
Domperidone IP 10 mg Excipients q.s.
Colour: Approved colour used.
|
|
247.
|
Naproxen Domperidone Tablets
|
Each film coated tablet contains:
Naproxen IP 500 mg
Domperidone IP 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
248.
|
Nebivolol Hydrochloride Tablets
|
Each uncoated tablet contains:
Nebivolol Hydrochloride IP
Equivalent to Nebivolol 5 mg
Excipients q.s.
|
|
249.
|
Nifedipine Sustained-Release Tablets IP 30 mg
|
Each film coated tablet contains:
Nifedipine IP 30 mg (As sustained-release form)
Excipients q.s.
Colour: Approved colour used.
|
|
250.
|
Nifedipine Sustained-Release Tablets IP 60 mg
|
Each film coated tablet contains:
Nifedipine IP 60 mg (As sustained-release form)
Excipients q.s.
Colour: Approved colour used.
|
|
251.
|
Nimesulide Tablets
|
Each uncoated tablet contains:
Nimesulide BP 100 mg
Excipients q.s.
Colour: Approved colour used.
|
|
252.
|
Nimesulide & Paracetamol Tablets
|
Each uncoated tablet contains:
Nimesulide BP 100 mg
Paracetamol IP 325 mg Excipients q.s.
|
|
253.
|
Nitrofurantonin Sustained Release Tablets
|
Each film coated sustained release tablet contains: Nitrofurantonin IP 100 mg Excipients q.s.
Colour: Approved colour used.
|
|
254.
|
Norfloxacin & Tinidazole Tablets
|
Each film coated tablet contains:
Norfloxacin IP 400 mg
Tinidazole IP 600 mg
Excipients q.s.
Colour: Quinoline Yellow & Titanium Dioxide IP
|
|
255.
|
Ofloxacin Tablets IP
|
Each film coated tablet contains:
Ofloxacin IP 200 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
256.
|
Ofloxacin Flavoxate Hydrochloride Tablets
|
Each film coated tablet contains:
Ofloxacin IP 200 mg
Flavoxate Hydrochloride IP 200 mg Excipients q.s.
Colour: Approved colour used.
|
|
257.
|
Ofloxacin & Ornidazole Tablets IP
|
Each film coated tablet contains:
Ofloxacin IP 200 mg
Ornidazole IP 500 mg
Excipients q.s.
Colour: Sunset Yellow FCF & Titanium Dioxide IP
|
|
258.
|
Olanzapine Tablets IP
|
Each uncoated mouth dissolving tablet contains: Olanzapine IP 5 mg
Excipients q.s.
|
|
259.
|
Olanzapine Tablets IP
|
Each uncoated mouth dissolving tablet contains: Olanzapine IP 7.5 mg
Excipients q.s.
|
|
260.
|
Olanzapine Tablets IP
|
Each uncoated mouth dissolving tablet contains: Olanzapine IP 10 mg Excipients q.s.
|
|
261.
|
Olanzapine Fluoxetine Tablets IP
|
Each uncoated tablet contains:
Olanzapine IP 5 mg
Fluoxetine IP 20 mg
Excipients q.s.
|
|
262.
|
Olanzapine Fluoxetine Tablets IP
|
Each uncoated tablet contains:
Olanzapine IP 10 mg
Fluoxetine IP 20 mg Excipients q.s.
|
|
263.
|
Olmesartan Medoxomil Tablets IP
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 20 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
264.
|
Olmesartan Medoxomil Tablets IP
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 10 mg Excipients q.s.
Colour: Approved colour used
|
|
265.
|
Olmesartan Medoxomil Tablets IP
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 40 mg Excipients q.s.
Colour: Approved colour used
|
|
266.
|
Olmesartan Amlodipine Besylate Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 20 mg Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
267.
|
Olmesartan Amlodipine Besylate Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 40 mg Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
268.
|
Olmesartan Chlorthalidone Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 20 mg
Chlorthalidone IP 12.5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
269.
|
Olmesartan Chlorthalidone Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 40 mg
Chlorthalidone IP 12.5 mg Excipients q.s.
Colour: Approved colour used.
|
|
270.
|
Olmesartan, Cilnidipine Chlorthalidone Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 40 mg
Cilnidipine IP 10 mg
Chlorthalidone IP 12.5 mg Excipients q.s.
Colour: Approved colour used.
|
|
271.
|
Olmesartan Medoxomil & Hydrochlorothiazide Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 20 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
Colour: Iron Oxide Red USP-NF & Titanium Dioxide IP
|
|
272.
|
Olmesartan Medoxomil & Hydrochlorothiazide Tablets
|
Each film coated tablet contains:
Olmesartan Medoxomil IP 40 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
Colour: Approved colour used.
|
|
273.
|
Olanzapine Tablets IP
|
Each uncoated tablet contains:
Olanzapine IP 5 mg
Excipients q.s.
|
|
274.
|
Ondansetron Orally Disintegrating Tablets
|
Each orally disintegrating tablet contains: Ondansetron Hydrochloride IP
Eq. to Ondansetron 4 mg
Excipients q.s.
|
|
275.
|
Oxcarbazepine Tablet IP
|
Each uncoated tablet contains:
Oxcarbazepine IP 150 mg
Excipients q.s.
|
|
276.
|
Oxcarbazepine Tablet IP
|
Each uncoated tablet contains:
Oxcarbazepine IP 300 mg Excipients q.s.
|
|
277.
|
Paracetamol Tablets IP
|
Each uncoated tablet contains:
Paracetamol IP 500 mg Excipients q.s.
|
|
278.
|
Paracetamol Tablets IP
|
Each uncoated tablet contains:
Paracetamol IP 650 mg Excipients q.s.
|
|
279.
|
Paracetamol, Phenylephrine Hydrochloride Chlorpheniramine Maleate Tablets
|
Each uncoated tablet contains:
Paracetamol IP 325 mg
Phenylephrine Hydrochloride IP 5 mg
Chlorpheniramine Maleate IP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
280.
|
Pantoprazole Gastro-resistant Tablets BP (For Export only)
|
Each enteric coated tablet contains: Pantoprazole Sodium Sesquihydrate BP
Eq. to Pantoprazole 40 mg .
Excipients q.s.
Colour: Approved colour used
|
|
281.
|
Pantoprazole Gastro-resistant Tablets IP
|
Each Gastro-resistan ttablet contains: Pantoprazole Sodium Sesquihydrate
Eq. to Pantoprazole 40 mg
Excipients q.s.
Colour: Iron Oxide Yellow USP-NF & Titanium Dioxide IP
|
|
282.
|
Pantoprazole Sodium Domperidone Tablets
|
Each film coated tablet contains:
Pantoprazole Sodium IP
Eq. to Pantoprazole 40 mg
Domperidone IP 10 mg Excipients q.s.
Colour: Approved colour used.
|
|
283.
|
Pantoprazole Sodium Domperidone Tablets
|
Each enteric coated tablet contains:
Pantoprazole Sodium IP
Eq. to Pantoprazole 40 mg
Domperidone IP 10 mg Excipients q.s.
Colour: Approved colour used.
|
|
284.
|
Paroxetine Prolonged-release Tablets IP
|
Each enteric coated prolonged-release tablet contains: Paroxetine Hydrochloride IP
Equivalent to Paroxetine 37.5 mg Excipients q.s.
Colour: Approved colour used
|
|
285.
|
Pioglitazone, Glimepiride & Metformin Hydrochloride SR Tablets
|
Each uncoated bilayered tablet contains: Pioglitazone Hydrochloride IP
Eq. to Pioglitazone 15 mg
Glimepiride IP 1 mg
Metformin Hydrochloride IP 500 mg (In Sustained Release Form)
Excipients q.s.
Colour: Lake of Indigo Carmine
|
|
286.
|
Pioglitazone, Glimepiride & Metformin Hydrochloride SR Tablets
(For Export only)
|
Each uncoated bilayered tablet contains: Pioglitazone Hydrochloride BP
Eq. to Pioglitazone 15 mg
Glimepiride BP 2 mg
Metformin Hydrochloride BP 500 mg (In Sustained Release Form)
Excipients q.s.
Colour: Approved colour used
|
|
287.
|
Pioglitazone & Metformin HCl Tablets
|
Each uncoated bilayered tablet contains: Pioglitazone Hydrochloride IP
Eq. to Pioglitazone 15 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
288.
|
Pioglitazone & Metformin Hydrochloride(SR) Tablets
|
Each uncoated bilayered tablet contains: Pioglitazone Hydrochloride IP
Eq. to Pioglitazone 15 mg
Metformin Hydrochloride IP 500 mg (As sustained release form )
Excipients q.s.
Colour: Approved colour used.
|
|
289.
|
Piracetam Tablets
|
Each film coated tablet contains:
Piracetam IP 800 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
290.
|
Piroxicam Tablets IP
|
Each film coated tablet contains:
Piroxicam IP 20 mg
Excipients q.s.
Colour: Approved colour used
|
|
291.
|
Piroxicam Dispersible Tablets
|
Each uncoated dispersible tablet contains:
Piroxicam IP 20 mg
Excipients q.s.
|
|
292.
|
Pitavastatin Calcium Tablets
|
Each film coated tablet contains: Pitavastatin Calcium IP
Eq. to Pitavastatin 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
293.
|
Pitavastatin Calcium Tablets
|
Each film coated tablet contains:
Pitavastatin Calcium IP
Eq. to Pitavastatin 4 mg
Excipients q.s.
Colour: Approved colour used.
|
|
294.
|
Prasugrel Hydrochloride Tablets IP
|
Each film coated tablet contains:
Prasugrel Hydrochloride IP
Eq. to Prasugrel 10 mg
Excipients q.s.
Colour: Approved colour used
|
|
295.
|
Pregabalin Tablets 25 mg
|
Each film coated tablet contains:
Pregabalin IP 25 mg
Excipients q.s.
Colour: Approved colour used
|
|
296.
|
Pregabalin Tablets 50 mg
|
Each film coated tablet contains:
Pregabalin IP 50 mg
Excipients q.s.
Colour: Approved colour used
|
|
297.
|
Pregabalin Tablets 75 mg
|
Each film coated tablet contains:
Pregabalin IP 75 mg
Excipients q.s.
Colour: Approvedcolour used
|
|
298.
|
Pregabalin Sustained-release Tablets
|
Each film coated tablet contains:
Pregabalin IP 75 mg (As Sustained-release form)
Excipients q.s.
Colour: Approved colour used
|
|
299.
|
Pregabalin Tablets 150 mg
|
Each film coated tablet contains:
Pregabalin IP 150 mg
Excipients q.s.
Colour: Approved colour used
|
|
300.
|
Pregabalin Tablets 300 mg
|
Each film coated tablet contains:
Pregabalin IP 300 mg
Excipients q.s.
Colour: Approved colour used
|
|
301.
|
Pregabalin Nortriptyline Hydrochloride Tablets
|
Each film coated tablet contains:
Pregabalin IP 37.5 mg
Nortriptyline Hydrochloride IP
Eq. to Nortriptyline 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
302.
|
Pregabalin Nortriptyline Hydrochloride Tablets
|
Each film coated tablet contains:
Pregabalin IP 75 mg
Nortriptyline Hydrochloride IP
Eq. to Nortriptyline 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
303.
|
Ramipril Tablets IP
|
Each uncoated tablet contains:
Ramipril IP 2.5 mg
Excipients q.s.
|
|
304.
|
Ramipril Tablets IP
|
Each uncoated tablet contains:
Ramipril IP 5 mg
Excipients q.s.
|
|
305.
|
Ranolazine Extended-Release Tablets 500 mg
|
Each film coated tablet contains:
Ranolazine 500 mg
(asextended-releaseform)
Excipients q.s.
Colour: Approved colour used.
|
|
306.
|
Ranitidine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Ranitidine Hydrochloride IP 150 mg Excipients q.s.
Colour: Approved colour used
|
|
307.
|
Ranitidine Hydrochloride Tablets IP
|
Each film coated tablet contains:
Ranitidine Hydrochloride IP 300 mg Excipients q.s.
Colour: Approved colour used
|
|
308.
|
Raltegravir Tablets IP
|
Each film coated tablet contains Raltegravir Potassium IP
Eq. to Raltegravir 400 mg
Excipients q.s.
Colour: Sunset Yellow FCF & Titanium Dioxide IP
|
|
309.
|
Ramipril & Hydrochlorothiazide Tablets IP
|
Each uncoated tablet contains:
Ramipril IP 5 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
|
|
310.
|
Repaglinide Tablets IP
|
Each uncoated tablet contains:
Repaglinide IP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
311.
|
Rizatriptan Orally Disintegration Tablets
|
Each Orally Disintegration tablet contains: Rizatriptan Benzoate IP
Eq. to Rizatriptan 10 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
312.
|
Rifampicin Isoniazid Tablets IP
|
Each film coated tablet contains:
Rifampicin IP 450 mg
Isoniazid IP 300 mg
Excipients q.s.
|
|
313.
|
Rifaximin Tablets BP
|
Each film coated tablet contains:
Rifaximin BP 200 mg
Excipients q.s.
Colour: Approved colour used
|
|
314.
|
Rifaximin Tablets BP
|
Each film coated tablet contains:
Rifaximin BP 400 mg
Excipients q.s.
Colour: Approved colour used
|
|
315.
|
Risperidone Tablets IP
|
Each uncoated tablet contains:
Risperidone IP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
316.
|
Risperidone Tablets USP (FOR EXPORT ONLY)
|
Each uncoated tablet contains:
Risperidone USP 2 mg
Excipients q.s.
Colour: Approved colour used.
|
|
317.
|
Rosuvastatin Tablets IP 10 mg
|
Each film coated tablet contains:
Rosuvastatin Calcium IP
Eq. to Rosuvastatin 10 mg
Excipients q.s.
Colours: Lake of Erythrosine & Titanium Dioxide IP
|
|
318.
|
Rosuvastatin Tablets IP10 mg
|
Each film coated tablet contains: Rosuvastatin Calcium IP
Eq. to Rosuvastatin 10 mg
Excipients q.s.
Colour: Approved colour used.
|
|
319.
|
Rosuvastatin Tablets IP20 mg
|
Each film coated tablet contains:
Rosuvastatin Calcium IP
Eq. to Rosuvastatin 20 mg
Excipients q.s.
Colours: Titanium Dioxide IP
|
|
320.
|
Rosuvastatin Tablets IP
|
Each film coated tablet contains:
Rosuvastatin Calcium IP
Eq. to Rosuvastatin 5 mg
Excipients q.s.
Colours: Lakeof Erythrosine & Titanium Dioxide IP
|
|
321.
|
Rosuvastatin Fenofibrate Tablets IP
|
Each film coated tablet contains: Rosuvastatin Calcium IP
Eq. to Rosuvastatin 10 mg
Fenofibrate IP 160 mg
Excipients q.s.
Colour: Approved colour used.
|
|
322.
|
Rosuvastatin Fenofibrate Tablets IP
|
Each film coated tablet contains: Rosuvastatin Calcium IP
Eq. to Rosuvastatin 20 mg
Fenofibrate IP 160 mg
Excipients q.s.
Colour: Approved colour used.
|
|
323.
|
Roxithromycin Tablets IP
|
Each film coated tablet contains:
Roxithromycin IP 150 mg Excipients q.s.
Colour: Approved colour used.
|
|
324.
|
Sertraline Hydrochloride Tablets IP
|
Each film coated tablet contains:
Sertraline Hydrochloride IP
Equivalent to Sertraline 50 mg
Excipients q.s.
Colour: Approved colour used
|
|
325.
|
Sertraline Hydrochloride Tablets IP
|
Each film coated tablet contains:
Sertraline Hydrochloride IP
Equivalent to Sertraline 100 mg Excipients q.s.
Colour: Approved colour used
|
|
326.
|
Sevelamer Carbonate Tablets 400 mg
|
Each film coated tablet contains:
Sevelamer Carbonate 400 mg Excipients q.s.
Colour: Approved colour used
|
|
327.
|
Sevelamer Carbonate Tablets 800 mg
|
Each film coated tablet contains:
Sevelamer Carbonate 800 mg Excipients q.s.
Colour: Approved colour used
|
|
328.
|
Sildenafil Citrate Tablets IP
|
Each film coated tablet contains:
Sildenafil Citrate IP
Eq. to Sildenafil 20 mg
Excipients q.s.
Colour: Approved colour used.
|
|
329.
|
Sildenafil Citrate Tablets IP
|
Each film coated tablet contains:
Sildenafil Citrate IP
Equivalent to Sildenafil 50 mg
Excipients q.s.
Colour: Approved colour used
|
|
330.
|
Sildenafil Citrate Tablets IP
|
Each film coated tablet contains:
Sildenafil Citrate IP
Equivalent to Sildenafil 100 mg
Excipients q.s.
Colour: Approved colour used
|
|
331.
|
Sildenafil Dapoxetine Tablets
|
Each film coated tablet contains:
Sildenafil Citrate IP
Equivalent to Sildenafil 50 mg Dapoxetine Hydrochloride IP
Equivalent to Dapoxetine 30 mg Excipients q.s.
Colour: Approved colour used
|
|
332.
|
Sildenafil Dapoxetine Tablets
|
Each film coated tablet contains:
Sildenafil Citrate IP
Equivalent to Sildenafil 100 mg Dapoxetine Hydrochloride IP
Equivalent to Dapoxetine 60 mg Excipients q.s.
Colour: Approved colour used
|
|
333.
|
Sildenafil Tadalafil Tablets (For Export Only)
|
Each film coated tablet contains:
Sildenafil Citrate USP
Eq. to Sildenafil 45 mg
Tadalafil USP 18 mg
Excipients q.s.
Colour: Approved colour used.
|
|
334.
|
Sitagliptin Tablets IP100 mg
|
Each film coated tablet contains:
Sitagliptin Phosphate Monohydrate IP
Equivalent to Sitagliptin 100 mg Excipients q.s.
Colour: Approved colour used
|
|
335.
|
Sitagliptin Phosphate Metformin Hydrochloride Tablets
|
Each film coated tablet contains:
Sitagliptin Phosphate Monohydrate IP
Equivalent to Sitagliptin 50 mg
Metformin Hydrochloride IP 500 mg Excipients q.s.
Colour: Approved colour used
|
|
336.
|
Sitagliptin Phosphate Metformin Hydrochloride Tablets
|
Each film coated tablet contains:
Sitagliptin Phosphate Monohydrate IP
Equivalent to Sitagliptin 50 mg
Metformin Hydrochloride IP 500 mg (as sustained release)
Excipients q.s.
Colour: Approved colour used
|
|
337.
|
Sitagliptin Phosphate Metformin Hydrochloride Tablets
|
Each film coated tablet contains:
Sitagliptin Phosphate Monohydrate IP
Equivalent to Sitagliptin 50 mg
Metformin Hydrochloride IP 1000 mg Excipients q.s.
Colour: Approved colour used
|
|
338.
|
Sitagliptin Phosphate Metformin Hydrochloride Tablets
|
Each film coated tablet contains:
Sitagliptin Phosphate Monohydrate IP
Equivalent to Sitagliptin 50 mg
Metformin Hydrochloride IP 1000 mg (as sustained release)
Excipients q.s.
Colour: Approved colour used
|
|
339.
|
Sirolimus Tablets
|
Each film coated tablet contains:
Sirolimus 1 mg
Excipients q.s.
Colour: Approved colour used
|
|
340.
|
Sirolimus Tablets
|
Each film coated tablet contains:
Sirolimus 2 mg
Excipients q.s.
Colour: Approved colour used
|
|
341.
|
Spironolactone Tablets IP
|
Each uncoated tablet contains:
Spironolactone IP 25 mg Excipients q.s.
|
|
342.
|
Spironolactone Tablets IP
|
Each uncoated tablet contains:
Spironolactone IP 50 mg Excipients q.s.
|
|
343.
|
Spironolactone Tablets IP
|
Each uncoated tablet contains:
Spironolactone IP 100 mg Excipients q.s.
|
|
344.
|
Sodium Bicarbonate Tablets USP
|
Each film coated tablet contains:
Sodium Bicarbonate USP 500 mg Excipients q.s.
Colour: Approved colour used
|
|
345.
|
Tadalafil Tablets IP
|
Each film coated tablet contains:
Tadalafil IP 10 mg
Excipients q.s.
Colour: Brilliant Blue FCF
|
|
346.
|
Tadalafil Tablets IP
|
Each film coated tablet contains:
Tadalafil IP 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
347.
|
Tadalafil Tablets IP
|
Each film coated tablet contains:
Tadalafil IP 10 mg
Excipients q.s.
Colour: Approved colour used
|
|
348.
|
Tadalafil Tablets IP
|
Each film coated tablet contains:
Tadalafil IP 20 mg
Excipients q.s.
Colour: Approved colour used
|
|
349.
|
Tapentadol Hydrochloride Tablets
|
Each film coated tablet contains:
Tapentadol Hydrochloride IP
Equivalent to Tapentadol 100 mg Excipients q.s.
Colour: Approved colour used
|
|
350.
|
Tapentadol Hydrochloride Tablets
|
Each film coated tablet contains:
Tapentadol Hydrochloride IP 50 mg Excipients q.s.
Colour: Approved colour used
|
|
351.
|
Tapentadol Hydrochloride Sustained Release Tablets
|
Each film coated sustained-release tablet contains: Tapentadol Hydrochloride IP 50 mg Excipients q.s.
Colour: Approved colour used.
|
|
352.
|
Tapentadol Hydrochloride Tablets
|
Each film coated tablet contains:
Tapentadol Hydrochloride IP 100 mg Excipients q.s.
Colour: Approved colour used.
|
|
353.
|
Tamsulosin Hydrochloride(MR) Tablets 0.4 mg
|
Each film coated tablet contains:
Tamsulosin Hydrochloride IP 0.4 mg (As modified release form)
Excipients q.s.
Colour: Approved colour used.
|
|
354.
|
Tamsulosin Hydrochloride(MR) & Dutasteride Tablets
|
Each film coated tablet contains:
Tamsulosin Hydrochloride IP 0.4 mg (As modified release form)
Dutasteride IP 0.5 mg
Excipients q.s.
Colour: Approvedcolour used.
|
|
355.
|
Telmisartan Tablets IP
|
Each uncoated tablet contains:
Telmisartan IP 20 mg
Excipients q.s.
|
|
356.
|
Telmisartan Tablets IP
|
Each uncoated tablet contains:
Telmisartan IP 40 mg
Excipients q.s.
|
|
357.
|
Telmisartan Tablets IP
|
Each uncoated tablet contains:
Telmisartan IP 80 mg
Excipients q.s.
|
|
358.
|
Telmisartan & Amlodipine Tablets IP
|
Each uncoated tablet contains:
Telmisartan IP 40 mg
Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Excipients q.s.
|
|
359.
|
Telmisartan & Amlodipine Tablets IP
|
Each uncoated bilayered tablet contains:
Telmisartan IP 40 mg
Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Excipients q.s.
Colour: Approved colour used
|
|
360.
|
Telmisartan & Amlodipine Tablets USP (For Export only)
|
Each film coated bilayered tablet contains: Telmisartan USP 40 mg .
Amlodipine Besylate USP
Eq. to Amlodipine 5 mg .
Excipients q.s.
Color:Approvedcolour used
|
|
361.
|
Telmisartan Chlorthalidone Tablets
|
Each uncoated tablet contains:
Telmisartan IP 40 mg
Chlorthalidone IP 12.5 mg Excipients q.s.
|
|
362.
|
Telmisartan Chlorthalidone Tablets
|
Each uncoated tablet contains:
Telmisartan IP 40 mg
Chlorthalidone IP 6.25 mg Excipients q.s.
|
|
363.
|
Telmisartan Chlorthalidone Tablets
|
Each film coated tablet contains:
Telmisartan IP 40 mg
Chlorthalidone IP 6.25 mg Excipients q.s.
Colour: Approved colour used
|
|
364.
|
Telmisartan, Chlorthalidone Metoprolol (E R) Tablets
|
Each film coated bilayered tablet contains: Telmisartan IP 40 mg
Chlorthalidone IP 12.5 mg
Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended release form)
Excipients q.s.
Colour: Approved colour used.
|
|
365.
|
Telmisartan Hydrochlorothiazide Tablets IP
|
Each uncoated bilayered tablet contains:
Telmisartan IP 40 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
Colour: Approved colour used
|
|
366.
|
Telmisartan Hydrochlorothiazide Tablets IP
|
Each uncoated bilayered tablet contains:
Telmisartan IP 80 mg
Hydrochlorothiazide IP 12.5 mg Excipients q.s.
Colour: Approved colour used
|
|
367.
|
Telmisartan, Hydrochlorothiazide Amlodipine Tablets
|
Each film coated tablet contains:
Telmisartan IP 40 mg
Hydrochlorothiazide IP 12.5 mg
Amlodipine Besylate IP
Eq. to Amlodipine 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
368.
|
Telmisartan, Cilnidipine Metoprolol (E R) Tablets
|
Each film coated bilayered tablet contains:
Telmisartan IP 40 mg
Cilnidipine IP 10 mg
Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended release form)
Excipients q.s.
Colour: Approved colour used.
|
|
369.
|
Telmisartan, Cilnidipine Metoprolol (ER) Tablets
|
Each film coated bilayered tablet contains:
Telmisartan IP 40 mg
Cilnidipine IP 10 mg
Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As extended release form)
Excipients q.s.
Colour: Approved colour used.
|
|
370.
|
Telmisartan(ImmediateRelease) & Metoprolol Succinate (Extended Release) Tablets
|
Each uncoated bilayered tablet contains:
Telmisartan IP 40 mg (In immediate release form)
Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (In extended release form)
Excipients q.s.
Colour: Approved colour used.
|
|
371.
|
Telmisartan(ImmediateRelease) & Metoprolol Succinate (Extended Release) Tablets
|
Each uncoated bilayered tablet contains:
Telmisartan IP 40 mg (In immediate release form)
Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (In extended release form)
Excipients q.s.
Colour: Approved colour used.
|
|
372.
|
Terbinafine Hydrochloride Tablets IP 250 mg
|
Each film coatedtablet contains: Terbinafine Hydrochloride IP
Eq. to Terbinafine 250 mg
Excipients q.s.
Colour: Approved colour used.
|
|
373.
|
Teneligliptin Tablets 10 mg
|
Each film coated tablet contains:
Teneligliptin Hydrobromide Hydrate IP
Eq. to Teneligliptin 10 mg
Excipients q.s.
Colours: Ferric Oxide Yellow USPNF & Titanium Dioxide IP
|
|
374.
|
Teneligliptin Tablets 20 mg
|
Each film coated tablet contains:
Teneligliptin Hydrobromide Hydrate IP
Eq. to Teneligliptin 20 mg
Excipients q.s.
Colours: Ferric Oxide Yellow USPNF & Titanium Dioxide IP
|
|
375.
|
Teneligliptin Tablets IP20 mg
|
Each film coated tablet contains:
Teneligliptin Hydrobromide Hydrate IP
Eq. to Teneligliptin 20 mg
Excipients q.s.
Color:Approved colour used
|
|
376.
|
Teneligliptin Metformin Hydrochloride(ER) Tablets IP
|
Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP
Eq. to Teneligliptin 20 mg
Metformin Hydrochloride IP 500 mg (As extended-release form)
Excipient q.s.
Colour: Approved colour used
|
|
377.
|
Ticagrelor Tablets IP
|
Each film coated tablet contains:
Ticagrelor IP 90 mg
Excipients q.s.
Colour: Approved colour used
|
|
378.
|
Tofacitinib Tablets IP
|
Each film coated tablet contains:
Tofacitinib Citrate IP
Eq. to Tofacitinib 5 mg
Excipients q.s.
Colour: Approved colour used.
|
|
379.
|
Tolperisone Hydrochloride Sustained Release Tablets
|
Each Sustained Release tablet contains:
Tolperisone Hydrochloride IP 450 mg Excipients q.s.
Colour: Titanium Dioxide IP
|
|
380.
|
Torsemide Tablets IP10 mg
|
Each film coated tablet contains:
Torsemide IP 10 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
381.
|
Torsemide Tablets IP
|
Each uncoated tablet contains:
Torsemide IP 10 mg
Excipients q.s.
|
|
382.
|
Torsemide Tablets IP 20 mg
|
Each film coated tablet contains:
Torsemide IP 20 mg
Excipients q.s.
Colour: Titanium Dioxide IP
|
|
383.
|
Torsemide Tablets IP40 mg
|
Each film coated tablet contains
Torsemide IP 40 mg
Excipients q.s.
Colour: Approved colour used
|
|
384.
|
Torsemide Tablets IP 100 mg
|
Each film coated tablet contains:
Torsemide IP 100 mg
Excipients q.s.
Colour: Approved colour used
|
|
385.
|
Torsemide Spironolactone Tablets
|
Each uncoated tablet contains:
Torsemide IP 10 mg
Spironolactone IP 50 mg
Excipients q.s.
|
|
386.
|
Torsemide Spironolactone Tablets
|
Each uncoated tablet contains:
Torsemide IP 20 mg
Spironolactone IP 50 mg
Excipients q.s.
|
|
387.
|
Tramadol Hydrochloride Tablets
|
Each uncoated tablet contains:
Tramadol Hydrochloride IP 100 mg
Excipients q.s.
|
|
388.
|
Tranexamic Acid Tablets IP
|
Each film coated tablet contains:
Tranexamic Acid IP 250 mg Excipients q.s.
Colour: Approved colour used
|
|
389.
|
Tranexamic Acid Tablets IP
|
Each film coated tablet contains:
Tranexamic Acid IP 500 mg Excipients q.s.
Colour: Approved colour used
|
|
390.
|
Tranexamic Acid & Mefenamic Acid Tablets
|
Each film coated tablet contains:
Tranexamic Acid IP 500 mg
Mefenamic Acid IP 250 mg Excipients q.s.
Colours: Yellow Oxide of Iron & Iron Oxide Red USP-NF
|
|
391.
|
Tranexamic Acid & Mefenamic Acid Tablets
|
Each film coated tablet contains:
Tranexamic Acid IP 500 mg
Mefenamic Acid IP 250 mg Excipients q.s.
Colour: Approved colour used.
|
|
392.
|
Thyroxine Sodium Tablets IP
|
Each uncoated tablet contains:
Thyroxine Sodium IP
Eq. to anhydrous Thyroxine Sodium 50 mcg Excipients q.s.
Colour: Approved colour used
|
|
393.
|
Ursodeoxycholic Acid Tablets IP
|
Each film coated tablet contains:
Ursodeoxycholic Acid IP 150 mg Excipients q.s.
Colour: Approved colour used
|
|
394.
|
Ursodeoxycholic Acid Tablets IP
|
Each film coated tablet contains:
Ursodeoxycholic Acid IP 300 mg Excipients q.s.
Colour: Approved colour used
|
|
395.
|
Valacyclovir Tablets USP500 mg
|
Each film coated tablet contains:
Valacyclovir Hydrochloride USP
Equivalent to Valacyclovir 500 mg Excipients q.s.
Colour: Approved colour used
|
|
396.
|
Valganciclovir Tablets IP
|
Each film coated tablet contains: Valganciclovir Hydrochloride IP
Equivalent to Valganciclovir 450 mg Excipients q.s.
Colour: Approved colour used
|
|
397.
|
Venlafaxine Extended-Release Tablets IP
|
Each uncoated tablet contains:
Venlafaxine Hydrochloride IP
Eq. to Venlafaxine 75 mg
(asextended-releaseform)
Excipients q.s.
Colour: Approved colour used.
|
|
398.
|
Vildagliptin Tablets IP
|
Each uncoated tablet contains:
Vildagliptin IP 50 mg
Excipients q.s.
|
|
399.
|
Vildagliptin Metformin HCl Tablets
|
Each uncoated bilayered tablet contains:
Vildagliptin IP 50 mg
Metformin Hydrochloride IP 500 mg (Sustained release)
Excipients q.s.
Colour: Brilliant Blue FCF & Titanium Dioxide IP
|
|
400.
|
Voglibose Mouth Dissolving Tablets
|
Each uncoated mouth dissolving tablet contains: Voglibose IP 0.2 mg
Excipients q.s.
|
|
401.
|
Voglibose Mouth Dissolving Tablets
|
Each uncoated mouth dissolving tablet contains: Voglibose IP 0.3 mg
Excipients q.s.
|
|
402.
|
Voglibose & Metformin Hydrochloride (SR) Tablets
|
Each uncoated bilayered tablet contains:
Voglibose IP 0.2 mg
Metformin Hydrochloride IP 500 mg (As sustained release form)
Excipients q.s.
Colour: Approved colour used.
|
|
403.
|
Voglibose & Metformin Hydrochloride (SR) Tablets
|
Each uncoated bilayered tablet contains:
Voglibose IP 0.3 mg
Metformin Hydrochloride IP 500 mg (As sustained release form)
Excipients q.s.
Colour: Approved colour used.
|
|
404.
|
Voglibose & Metformin HCl Tablets
|
Each uncoated tablet contains:
Voglibose IP 0.3 mg
Metformin Hydrochloride IP 500 mg
Excipients q.s.
|